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Objectives: Mild level of iodine deficiency during pregnancy may reduce maternal thyroid 
hormone production and supply to the fetus hence affecting brain neurodevelopment. 
The aim of the present study was to investigate the association between elevated neo-
natal thyroid-stimulating hormone (TSH) level (>5 mU/L), used as a marker of maternal 
mild iodine deficiency during late pregnancy, and behavioral development of preschool 
children.
Methods: This retrospective cohort study included 310 Belgian mothers and their chil-
dren aged 4–5 years old with TSH levels in the range of 0.45–15 mU/L at birth. The TSH 
level was measured in dried blood spots on filter paper collected by heel stick 3–5 days 
after birth. Low birth weight, prematurely born children, or children with congenital 
hypothyroidism were excluded. The degree of behavioral problems was evaluated using 
the Child Behavior Check List (CBCL) for age 1½–5 years questionnaire. Relevant socio-
economic, maternal, and child factors were also collected.
results: TSH concentrations and CBCL scores were not associated both in univariate 
analysis and when adjusting for confounding factors in multivariate analysis.
Discussion: Elevated TSH concentrations measured at birth was not associated with 
behavioral development scores.
Keywords: behavioral problems, thyroid-stimulating hormone, preschool children, iodine deficiency, pregnancy
inTrODUcTiOn
Iodine is essential for the synthesis of thyroid hormones that are involved in many functions includ-
ing brain development (1, 2). While severe iodine deficiency is disappearing worldwide, mild iodine 
deficiency (MID) is still present in many developed countries (3).
Abbreviations: ADHD, attention deficit hyperactivity disorder; CBCL, Child Behavior Checklist; DSM, diagnostic and statisti-
cal manual of mental disorders; fT4, free thyroxine; MID, mild iodine deficiency; mU/L, micro international unit/liter; T4, 
thyroxin; TPOAbs, thyroid peroxidase antibodies; TSH, thyroid-stimulating hormone; ULB, Université Libre de Bruxelles; 
UIC, urinary iodine concentration; WHO, World Health Organization.
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Pregnant women are at a higher risk of iodine deficiency 
because their nutritional iodine requirements are almost doubled 
due to physiological changes. Thyroid hormones are involved 
in several important steps of brain development including cell 
migration and differentiation (4). A sufficient transfer of maternal 
thyroid hormones to the fetal brain is necessary from the early 
stage of pregnancy, and a lack of thyroid hormones during 
pregnancy may disturb the brain development of the fetus. Even 
MID can lead to mild thyroid dysfunction that may affect the 
fetal brain development (5). Insufficient iodine stock can lead 
to maternal hypothyroxinemia that is a common condition in 
pregnancy characterized by a low level of free thyroxin with 
thyroid-stimulating hormone (TSH) within the normal range 
(6). Several studies have shown that maternal hypothyroxinemia 
can lead to impaired cognitive and psychomotor development in 
offspring (5, 7).
Little is known about the impact of mild thyroid dysfunction 
during pregnancy on behavioral development of children. A 
prospective study conducted in an geographic area of moderate 
iodine deficiency in Italy found that children of hypothyrox-
emic mothers had an increased risk of developing attention 
deficit hyperactivity disorder (ADHD) symptomatology (8). 
However, that study was conducted on a very limited size 
sample. Two larger researches have been conducted in order 
to investigate the effect of maternal hypothyroxinemia on 
behavioral development of the offspring. One of these found a 
relationship between higher levels of maternal TSH and higher 
externalizing scores in children aged 1½ and 3 years old, while 
no association was found between maternal fT4 and total T4 
and behavioral problem scores in children (9). In contrast, 
the second study found that maternal hypothyroxineamia was 
linked to an increased risk of showing ADHD symptoms at 
8 years old (10).
Another study found that MID during pregnancy, measured 
by urinary iodine excretion, was related in children of 4 years of 
age to impaired executive functioning (11), impairments that 
are known to be related to behavioral problems such as ADHD, 
oppositional defiant disorder, or conduct disorder (11).
Put together, these data indicate a potential implication of 
maternal and/or fetal thyroid dysfunction in the vulnerability of 
children to behavioral problems. However, the number of studies 
is limited and their results are controversial, thereby requiring 
further studies.
Thyroid-stimulating hormone concentration in whole 
blood measured at birth has been proposed as an indicator of 
maternal iodine status during late pregnancy (12–14). When 
thyroid disease is excluded, the thyroid hormone level is mainly 
dependent on body iodine stocks provided by nutrition. TSH 
is liberated in the bloodstream to stimulate the production of 
thyroid hormones when they are lacking. When their amount is 
adapted, TSH secretion is stopped by a negative feedback loop. 
In cases of iodine deficiency, iodine stocks are insufficient to 
produce thyroid hormones, and the TSH concentration increases 
in the bloodstream. Following this logic, an increased concentra-
tion can be used as an indicator of iodine deficiency. The world 
health organization (WHO) has proposed to use the TSH results 
provided by screening programs for congenital hypothyroidism 
as an index for the evaluation of iodine status of the population 
(12). A proportion of TSH results with a concentration above 
5 mU/L below 3% was proposed as an indicator of iodine suf-
ficiency, between 3 and 19.9% of MID, between 20 and 39.9% 
of moderate iodine deficiency and above 40% of severe iodine 
deficiency (12).
Several studies showed that elevated TSH levels after birth were 
associated with suboptimal cognitive and psychomotor outcomes 
(15–19). However, some factors other than iodine deficiency can 
increase TSH concentration at birth such as timing of testing, 
mothers or newborn health condition, and drug intake (20, 21). 
We previously reported no association between elevated TSH 
measured at birth and cognitive and psychomotor development 
of preschool children when confounding factors were taken into 
account (22, 23).
To our knowledge, the association between elevated neonatal 
TSH and behavioral problems has never been investigated.
The aim of this study was to investigate the association 
between elevated TSH concentration at birth, used as a marker 
of MID during late pregnancy, and behavioral development of 
preschool-age children, taking into account potential confound-
ing factors. We hypothesized that a higher TSH level in newborn 
children would be related to the childrens’ increased tendency 
to internalize and externalize problems, assessed using the age-
adapted Child Behavior Check List questionnaire.
MaTerials anD MeThODs
subjects
We used data from the PsychoTSH study, a Belgian retrospective 
cohort study that has been previously described in detail (22–24). 
In total, 310 children aged 4–5  years old with a neonatal TSH 
concentration in the range 0.45–15 mU/L were included in the 
present study. Neonatal TSH data were provided by the Brussels 
newborn screening center for metabolic disorders [Laboratoire 
de Pédiatrie, Université Libre de Bruxelles (ULB), Brussels]. The 
selection of children was performed from the total samples of, 
respectively, 29,013, 29,602, and 30,126 neonates, screened in 
2008, 2009, and 2010. Children were stratified by sex and TSH 
level: for each sex and TSH interval, 19 children were selected 
randomly (0–1, 1–2, 2–3, 3–4, 4–5, 5–6, 6–7, 7–8, 8–9, and 
9–15  mU/L). The day of collection was taken into account for 
the selection, only children with sample collected 3–5 days after 
birth were included. Exclusion criteria were (1) congenital hypo-
thyroidism (15 mU/L or higher), (2) prematurity (<37 weeks), 
and (3) low birth weight (<2,500 g). Children with neurological 
disease and/or born from multiple birth were excluded during 
the recruitment procedure. The sample size of the TSH study was 
calculated for the relationship between TSH and cognitive score 
(22, 24).
ethics and Privacy commission
Before the start of the procedure, a written informed consent was 
obtained from the parents of the children. The Ethical Committee 
of the Erasmus Hospital (Université Libre de Bruxelles, Brussels, 
Reference CCB: B40620109191) in accordance with the Code of 
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Ethics of the World Medical Association for experiments involv-
ing humans (Declaration of Helsinki) gave the ethical approval 
of the study. The study was also approved by the Belgian Privacy 
Commission (Reference: RN 29/2012).
Tsh Measurements
Neonatal TSH level was measured in dried blood spots on 
filter paper collected by a heel stick 3–5  days after birth using 
a time-resolved fluoroimmunoassay (Autodelfia method) (25). 
The reproducibility of the TSH values was tested in the range 
0–15  mU/L. In order to determine the coefficient of variation, 
TSH was analyzed twice at 50 different TSH values. For the TSH 
values ranging from 0.9 to 15 mU/L, the coefficient of variation 
was below 20%. For the TSH values below 0.9 mU/L, a TSH value 
of 0.45 mU/L was used in the statistical analysis.
Urinary iodine concentration (Uic) 
assessment
A sample of urine was collected from the child during the home 
visit (at 4–5 years) to determine the current iodine status among 
the children included in the study. The urine samples were frozen 
at −80°C until analysis. Urinary iodine concentration (UIC) was 
measured using a modification of the Sandell–Kolthoff reaction 
with spectrophotometric detection (26) at the Erasmus Hospital.
anthropometric Measurements 
Methodology
During the procedure, body weight, height, and child head 
circumference were measured using SECA 815 and SECA 804 
scales, a SECA 214 stadiometer and a flexible tape measure 
SECA 212.
Psychosocial assessment
Psychosocial development, including behavioral and emotional 
problems, was assessed using the French version of the “Child 
Behavior Check List (CBCL) for ages 1½–5 years.” This standard-
ized questionnaire was developed by Achenbach assessing social 
competence, behavioral, and emotional problems in children 
aged 1½–5 years old (27). The CBCL/1½–5 has a good reliability 
and validity (27). The syndrome scales has been shown to have 
an acceptable to good fit in 23 studies across diverse societies 
(28). The internal consistency of internalizing and externalizing 
syndrome scales has been tested previously and Cronbach’s alpha 
vary between 0.88 and 0.92 (29). The Child Behavior Checklist 
has been used previously in preschool children to assess the 
effect of maternal thyroid dysfunction on behavioral problem (7, 
9) or the effect of subclinical hypothyroidism on psychosocial 
development (30).
The CBCL questionnaire was filled out by mothers during a 
home visit. It enables the rating of problematic behaviors based 
on a description of the child’s functioning for the last two months. 
The CBCL enables the calculation of 3 scores: a total problem 
score, a score on internalizing problems, and a score on external-
izing problems.
The internalizing problems score is calculated from the follow-
ing four syndrome scales: emotional reactive, anxious depressed, 
somatic complaints, and withdrawal. The externalizing problems 
score is calculated from the following two syndrome scales: atten-
tion problems and aggressive behavior. The total problems score 
includes internalizing and externalizing scores together with the 
“sleep problems” syndrome scale.
In addition to those three scores, the CBCL checklist enables 
the calculation of the following DSM-oriented scores: affective 
problems, anxiety problems, pervasive developmental problems, 
attention deficit/hyperactivity problems, and oppositional defiant 
problems.
The Achenbach’s manual provides functioning cut-off points 
in order to differentiate between a “normal” and a “problematic” 
score. These cut-off points provide a normal (below 65), a bor-
derline (between 65 and 70), and a clinical range (higher than 
70) for the scores.
The ASEBA Windows software Assessment Data Manager 
(ADM) was used to compute the scores.
Descriptive Variables, covariates,  
and effects Modifiers
Information about covariates and effect modifiers was retrieved 
from the data provided by the ULB newborn screening center for 
metabolic disorders, the child’s health booklet, and a self-report 
questionnaire filled out by the mother during the home visit.
The following information was collected about the pregnancy 
history and the maternal antecedents: maternal thyroid disease, 
drug intake, alcohol consumption and cigarette smoking before 
or during pregnancy, gestational diabetes and treatment of 
diabetes, maternal age at birth, reproductive history, parity, 
gravidity, pre-pregnancy body mass index (BMI), and maternal 
weight gain during pregnancy. The following information was 
collected about the delivery: type of delivery and season of birth. 
The following child parameters were retrieved: perinatal anoxia, 
health problems of the newborn, breastfeeding, chronic disease 
of the child, nursery school attendance, child bilingualism, and 
previous cognitive assessment of the child. The socioeconomic 
background data collected were as follows: maternal/paternal 
education and employment, household income, marital status, 
area of residence, maternal age, housing.
In addition, several questions contained in the self-reported 
questionnaire aimed to assess different psychological factors 
potentially influencing the mental development of the child: 
child negative life events, maternal mental health, maternal 
social support, marital discord and parent–child interactions. 
Maternal mental health was also assessed using the “General 
Health Questionnaire” items and vitality scale questionnaire of 
the “Short Form Health Survey” (31).
Data analysis
Statistical analysis was performed using SAS statistical software 
9.3 (SAS Institute Inc., Cary, NC, USA) for univariate analysis 
and Stata version 13 (StataCorp, College Station, TX, USA) for 
multivariate analysis. Statistical tests were two-sided and tests 
with p-value < 0.05 were considered statistically significant.
TaBle 1 | Descriptive and demographic characteristics of the study 
population according to gender.
Total Male Female
N % N % N %
Thyroid-stimulating hormone level at birth (mU/l)
0.45–1 47 15.2 26 8.4 21 6.8
2 35 11.3 21 6.8 14 4.5
3 41 13.2 23 7.4 18 5.8
4 40 12.9 20 6.5 20 6.5
5 34 11.0 19 6.1 15 4.8
6 39 12.6 20 6.5 19 6.1
7 35 11.3 21 6.8 14 4.5
8 14 4.5 10 3.2 4 1.3
9 14 4.5 6 1.9 8 2.6
10–15 11 3.6 7 2.3 4 1.3
age at examination
4 years 234 75.5 130 42.0 104 33.5
5 years 76 24.5 43 13.9 33 10.6
children ethnicity
Europe (Caucasian) 248 84.6 139 47.4 109 37.2
Asia 3 1.0 2 0.7 1 0.3
Sub-Saharan Africa 15 5.1 7 2.4 8 2.7
North Africa 27 9.2 16 5.5 11 3.8
PsychoTSH study (N = 310), Belgium, 2008–2014.
N, number of subjects.
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Neonatal TSH values and UIC were presented as median, and 
IQR and CBCL scores were presented as mean and SD. Neonatal 
TSH values were classified in two groups: below 5  mU/L and 
higher or equal to 5 mU/L.
Univariate associations between CBCL scores and TSH 
were assessed using Pearson correlation. Univariate association 
between CBCL scores and maternal and children parameters was 
assessed using linear regression for continuous variables and with 
student’s t-test and ANOVA with Bonferroni correction for cat-
egorical variables. In addition, Chi square test was performed to 
analyze multivariate association between TSH levels (<5 mUI/L 
and ≥5  mUI/L) and borderline (65< and <70)/clinical score 
(≥70) at CBCL checklist.
Multivariate linear models were used to study the predictors 
of variation of CBCL scores in children. All variables associated 
with CBCL scores with a test p <  0.20 were included in the 
selection procedure. TSH was dichotomized using a cut-off of 
5 mU/L. A stepwise backward selection procedure with a prob-
ability of entry of 0.10 and exit probability of 0.15 was used to 
build the final multiple linear regression models. The normality 
of the distribution of residuals was tested using normal plot 
of residuals. Linearity and homoscedasticity of residuals were 
checked by examination of the plot of standardized residual. 
Collinearity between predictors was tested using the test of 
variance inflation factor (VIF), and individuals’ VIF for each 
parameter in the model was around 1. Univariate association 
between the variables to be inserted in the model was tested with 
Pearson correlation. Variables correlated with each other were 
not included together in the model.
resUlTs
Demographic characteristics
Descriptive characteristics by gender of the population studied 
are shown in Table 1. In total, 310 children (n = 137 girls) aged 4 
and 5 years were included in the study.
neonatal Tsh levels at Birth and current 
iodine status of the studied Population
The median (range) TSH level at birth of the study sample was 
3.6 mU/L [1.8–5.8 (IQR), 0.45–13.9 (min–max)]. In this sample, 
197 (63.5%) children had a TSH level measured at birth lower 
than 5 mUI/L, and 113 (36.5%) children had a TSH higher or 
equal to 5 mUI/L. The median iodine concentration of the sample 
was 141.4 µg/L [87.9–239.9 (IQR)] indicating iodine sufficiency 
of the children sample.
Univariate association between cBcl 
scores and studied Parameters
The mean CBCL total problem score was 48.0 [10.1 (SD), 28–88 
(min–max)]; the mean CBCL external problem score was 46.7 
[9.5 (SD), 28–77 (min–max)]; and the mean CBCL internal 
problem was 49.5 [11.1 (SD), 29–86 (min–max)].
Several child, maternal, socioeconomic, and iodine status 
parameters were shown to be associated with CBCL scores in 
univariate analysis (see Tables 2–4). A negative association was 
found between neonatal TSH concentration, CBCL total problem 
score (p = 0.038) and internalizing problem score (0.023). No sig-
nificant associations were found between DSM-oriented scores 
and neonatal TSH levels (data not shown).
neontal Tsh concentration and severity 
rating at cBcl scores
Child Behavior Check List scores in the borderline and clini-
cal range were not more frequently found in the children with 
elevated TSH compared to those with TSH < 5 mU/L as shown 
in Figure 1.
Predictors of cBcl scores assessed by 
Multiple linear regression analysis
The multiple linear regressions of factors explaining variation of 
CBCL scores at preschool age are shown in Table 5. Elevated TSH 
concentration at birth was not associated with any CBCL scores. 
The predictors of higher CBCL scores (meaning higher problems 
score) were male gender (total problem score, p = 0.008; external-
izing score, p = 0.001), no dietary supplement intake by the child 
(total problem score, p = 0.003; externalizing score, p = 0.006), 
neonatal hospital attendance (total problem score, p =  0.023; 
internalizing score p =  0.093), child negative life event occur-
rence (total problem, score, p = 0.008), maternal education level 
lower than university (total problem score, p < 0.0001; external-
izing score, p < 0.0001; internalizing score p < 0.0001), mother’s 
lifetime smoking behavior up to child birth (internalizing score, 
p  =  0.031), maternal suboptimal vitality (externalizing score, 
p = 0.009), and higher maternal mental distress (total problem 
score, p < 0.0001).
TaBle 2 | association of cBcl scores at preschool age with infant, maternal, and household characteristics: categorical variables.
Total Total problem score externalizing score internalizing score
N % Mean sD p-Valuea Mean sD p-Valuea Mean sD p-Valuea
children characteristics
Gender 0.082 0.004 0.381
Male 173 55.81 48.87 10.31 48.05 10.07 50.05 10.86
Female 137 44.19 46.86 9.74 44.96 8.50 48.94 11.31
Neonatal hospital attendance 0.028 0.117 0.047
Yes 24 8.00 52.04 12.93 49.33 10.52 53.58 12.93
No 276 92.00 47.36 9.68 46.19 9.28 48.92 10.80
Breastfeeding at 6 months 0.121 0.034 0.165
<6 months 150 48.54 47.07 9.83 45.73 9.08 * 48.64 11.11
>6 months 123 39.81 48.06 9.46 46.55 9.09 49.71 10.59
no breastfeeding 36 11.65 50.92 12.82 50.31 11.68 * 52.53 12.39
Negative life event 0.013 0.056 0.019
Less than 3 267 86.41 47.38 9.76 46.22 9.27 48.97 10.92
More than 3 42 13.59 51.55 11.49 49.24 10.56 53.29 11.46
socioeconomics characteristics
Monthly income 0.001 0.054 0.006
<2,000 euro 38 12.67 52.70 11.92 49.22 10.21 54.14 11.97
≥2,000 euro 262 87.33 47.06 9.71 46.02 9.31 48.71 10.92
Mother education level <0.0001* 0.001* <0.0001*
No/primary 10 3.28 52.20 11.32 51.60 10.75 53.90 9.85
Lower high school 22 7.21 56.90 10.50 51.76 9.20 58.62 10.53
Upper high school 50 16.39 51.14 8.75 49.20 7.17 52.59 9.99
University or higher 223 73.11 46.10 9.74 45.29 9.67 47.79 10.96
Maternal characteristics
Delivery 0.097 0.225 0.172
Normal 234 75.73 47.19 10.06 46.11 9.47 48.73 11.13
Cesarean 43 13.92 49.16 8.91 46.95 8.76 51.86 9.93
With vacuum 31 10.03 51.65 11.57 49.65 10.23 52.16 12.01
With forcepts 1 0.32 43.00 40.00 45.00
Parity—First child 0.006 0.158 0.002
Yes 132 42.72 49.77 9.48 47.52 9.00 51.78 10.29
No 177 57.28 46.55 10.38 45.98 9.78 47.78 11.39
Previous miscarriage 0.012 0.026 0.150
Yes 76 24.68 50.35 11.76 48.65 10.18 51.01 12.78
No 232 75.32 47.00 9.37 45.84 9.15 48.89 10.43
Smoking during pregnancy 0.000 0.001 0.001
 ≥ 10 cigarettes/day 6 1.94 62.83 14.16 59.00 12.41 64.33 11.04
<10 cigarettes/day or 
non-smoking
304 98.06 47.69 9.81 46.44 9.32 49.27 10.87
Alcohol during pregnancy 0.356 0.786 0.168
Non-consumer 209 68.08 48.26 9.98 46.69 9.14 50.08 10.91
Still consuming 98 31.92 47.11 10.42 46.38 10.23 48.20 11.45
Mother social support 0.019 0.098 0.133
3 or less 98 31.72 49.91 10.78 47.94 9.20 50.92 11.71
4 or more 211 68.28 46.98 9.70 46.00 9.63 48.87 10.78
Mother mental distress score <0.0001 0.031 <0.0001
Low (<4) 259 88.10 47.16 9.83 46.17 9.36 48.86 10.87
Elevated (>4) 35 11.90 53.69 11.62 49.89 10.67 55.89 11.31
Mother vitality Index 0.085 0.023 0.570
Optimal vitality 269 89.07 48.25 10.18 47.15 9.45 49.50 11.32
Suboptimal vitality 33 10.93 44.97 9.92 43.09 9.46 48.31 10.15
PsychoTSH study (N = 310), Belgium, 2008–2014.
A higher CBCL score is related to higher developmental problems.
ap-Value from simple t-test or ANOVA.
*Significant with Bonferroni correction for multiple testing.
N, number of subject.
Statistically significant p-Values (p < 0.05) are highlighted in bold.
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TaBle 4 | cBcl scores at preschool age and markers of iodine status.
Total problem score externalizing score internalizing score
N % Mean sD p-Valuea Mean sD p-Valuea Mean sD p-Valuea
Pregnancy and neonatal period
Neonatal TSH level (mU/L) 0.152 0.051 0.266
<5 197 63.55 48.60 10.30 47.49 9.66 50.09 11.19
≥5 113 36.45 46.89 9.68 45.29 9.16 48.64 10.81
Vitamins during pregnancy 0.191 0.286 0.139
Containing iodine 51 43.59 47.43 9.29 46.02 8.67 48.73 10.76
No vitamins 66 56.41 49.89 10.41 47.98 10.51 51.73 10.63
children characteristics
Urinary iodine concentration (μg/L) 0.086 0.116 0.098
<100 82 30.37 48.37 9.90 47.18 9.20 49.90 10.93
100–149 67 24.81 49.12 10.69 47.98 9.79 50.65 11.96
150–294 60 22.22 46.36 9.28 44.59 9.27 49.27 10.27
≥250 61 22.59 45.11 9.42 44.92 9.57 46.11 10.08
Household salt 0.189 0.092 0.356
Iodinised salt 96 34.53 47.39 9.77 46.42 9.63 48.82 10.91
Non-iodinised salt 170 61.15 47.63 10.11 45.99 9.31 49.40 11.05
No salt 12 4.32 53.00 13.64 52.25 11.89 53.75 14.72
Child dietary supplement intake 0.004 0.004 0.025
Yes 196 65.55 46.71 9.54 45.54 9.12 48.47 10.71
No 103 34.45 50.26 10.60 48.84 9.87 51.50 11.47
PsychoTSH study (N = 310), Belgium, 2008–2014.
A higher CBCL score is related to higher developmental problems.
ap-Value from simple t-test or ANOVA.
*Significant with Bonferroni correction for multiple testing.
N, number of subject.
Statistically significant p-Values (p < 0.05) are highlighted in bold.
TaBle 3 | association of cBcl scores at preschool age with infant, maternal, and household characteristics: continuous variables.
Total problem score externalizing score internalizing score
Pearson correlation
N Median iQr r p-Valuea R p-Valuea R p-Valuea
TSH (mUI/L) 310 3.6 1.8–5.9 −0.12 0.038 −0.10 0.081 −0.13 0.023
Univariate linear regression
N Mean sD b se Pb b se Pb b se Pb
Term pregnancy (week) 308 39.3 1.6 −0.26 0.36 0.481 −0.25 0.34 0.473 −0.37 0.40 0.360
Birth weight (g) 310 3,394.2 429.8 0.00 0.00 0.968 0.00 0.00 0.660 0.00 0.00 0.314
Birth length (cm) 310 50.0 3.2 −0.14 0.18 0.444 −0.04 0.17 0.806 −0.27 0.20 0.187
Birth HC (cm) 269 34.6 3.1 0.21 0.19 0.267 0.18 0.18 0.334 0.18 0.21 0.389
Mother age (years) 310 36.5 5.1 −0.18 0.11 0.117 −0.07 0.11 0.498 −0.26 0.12 0.040
PsychoTSH study (N = 310), Belgium, 2008–2014.
A higher CBCL score is related to higher developmental problems.
ap-Value from Pearson Correlation.
bp-Value from Univariate Linear Regression.
IQR, inter quartile range; HC, head circumference; N, number of subject.
Statistically significant p-Values (p < 0.05) are highlighted in bold.
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DiscUssiOn
Our study was the first to investigate the association between the 
elevation of neonatal TSH level at birth, used as a marker for iodine 
deficiency during late pregnancy, and the subsequent behavioral 
development of the offspring. Children with a neonatal TSH above 
5 mU/L—used as a marker of iodine deficiency during late preg-
nancy—were found to have similar internalizing and externalizing 
behavioral problems scores to children with lower neonatal TSH 
levels, after adjusting for children and maternal covariates.
FigUre 1 | neonatal Tsh concentration and severity rating at cBcl scores. PsychoTSH study (N = 310), Belgium, 2008–2014. Clinical T-scores <65, 
borderline <65 and <70, and clinical >70. Chi-squared test of independence was non-significant. ODP, oppositional defiant problems; ADHD, attention-deficit 
hyperactivity disorder; TSH (mUI/L), thyroid-stimulating hormones.
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Major factors associated with higher CBCL scores (indicative 
of higher problems) in multivariate analysis in preschool chil-
dren were: male gender, neonatal hospital attendance, no dietary 
supplement intake by the child, negative life child events, lower 
maternal education level, maternal lifetime smoking behavior up 
to child birth, maternal psychological distress, and maternal low 
vitality. Previous research has shown that maternal MID and/or 
mild thyroid dysfunction could lead to behavioral problems in 
offspring later in life. A prospective study conducted in Sicily, 
Italy, investigated neuropsychological profiles of 16 children aged 
8–10 years old living in a area with moderate iodine deficiency 
and 11 children in a control group living in an iodine-sufficient 
area in regards to the thyroid function of their mother during 
pregnancy (8). They found that 68% of the children showed 
ADHD symptoms in the iodine deficient area compared to no 
children in the iodine-sufficient area. In the iodine deficient area, 
87.5% of the children born from hypothyroxinemic mothers had 
ADHD (8). A study conducted on the Dutch Generation R cohort 
found that maternal hypothyroxineamia during pregnancy was 
linked to an increased risk of showing ADHD symptoms at 
8 years of age (10).
Another study conducted on the Generation R cohort study 
found that MID during pregnancy, measured by urinary iodine 
excretion, was related with impaired executive functioning in chil-
dren of 4 years old (11). Executive functioning involves inhibition, 
working memory, and organization skills. Impairments in cogni-
tive functioning have been linked to behavioral problems such as 
ADHD, oppositional defiant disorder, or conduct disorder (11).
In line with the findings of our study, several other studies 
did not find any relationship between mild thyroid dysfunction 
potentially due to MID (maternal low fT4) and behavioral prob-
lems in the offspring.
A study on the Generation R study cohort found no asso-
ciation between maternal fT4 measured before 18th weeks of 
pregnancy and total T4 and CBCL behavioral problems scores in 
children at 1½ and 3 years old (9). On the other hand, they found 
a relationship between higher levels of maternal TSH and higher 
externalizing scores in children at 1½ and 3 years old. A study 
carried out in Finland on 9,479 children aged 8 years old in order 
to look for an association between maternal thyroid dysfunction 
and ADHD in the offspring found similar results. No associa-
tion between maternal low fT4 during pregnancy and ADHD in 
the offspring was found (32). However, girls whose mother had 
elevated TSH levels during pregnancy had a higher risk of ADHD 
(32). In contrast to those findings, a Danish epidemiological study 
(N = 30,295) found no relationship between maternal hypothy-
roidism and ADHD symptoms in the offspring (33). A higher 
risk of ADHD in children whose mothers were diagnosed with 
hyperthyroidism after childbirth (vs. the one diagnosed prior to 
childbirth) was observed (33).
In the Netherlands, the Generation R study cohort (N = 3,139) 
investigated the association between thyroid peroxidase antibod-
ies (TPOAbs) in healthy pregnant women and child behavior, 
using the Child Behavior Checklist. A higher risk of behavioral 
problems and ADHD was found in children whose mothers had 
elevated TPOAbs during pregnancy (7).
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Studies such as ours, which investigate the impact of neonatal 
TSH levels as an indicator of MID during pregnancy (16–18, 
34), only indicate the iodine status during late pregnancy. 
Subclinical impairment of cognitive and psychomotor develop-
ment secondary to maternal hypothyroxineamia were found 
in studies investigating the first half of pregnancy (35–38). 
In several studies, no adverse outcomes were observed when 
hypothyroxineamia was studied from midpregnancy (39, 
40). However, some studies did not find neurodevelopmental 
problems in children of mothers with hypothyroxinemia (41) 
or low urinary iodine excretion measured in the first trimester 
of pregnancy (42).
The present study was conducted on a large sample stratified 
by gender and TSH ensuring that the whole range of TSH values 
below the clinical threshold for the diagnosis of congenital 
hypothyroidism was included. According to WHO, a proportion 
of neonates with a concentration of TSH above 5 mUI/L between 
3 and 19% indicates MID (12). In Belgium, the frequency of neo-
natal TSH concentrations above 5 mUI/L fluctuated between 2.6 
and 3.3% from 2009 to 2011 (43). This proportion was very low 
in comparison to results found for Belgian women of childbear-
ing age. Indeed a study has shown that they had a median UIC 
indicative of MID in the year 2010–2011 (44). However, a median 
UIC indicative of iodine sufficiency was found in school-aged 
children (45).
Many factors other than iodine deficiency can influence TSH 
measured at birth such as the timing of the blood sampling, the 
use of iodine-containing antiseptics around birth, or exposure 
to some organochlorines called endocrine disruptors (20, 21). 
The effect of MID during pregnancy on children behavioral 
development should thus be complemented by prospective 
studies using other markers of iodine deficiency during from 
first trimester of pregnancy, such as maternal UIC or maternal 
hypothyroxinemia.
TaBle 5 | Multiple linear regression of factors explaining variation of cBcl scores at preschool age.
Total problem score (N = 269) externalizing score (N = 282) internalizing score (N = 289)
R2 = 22% R2 = 14% R2 = 13%
b (se) p-Value b (se) p-Value b (se) p-Value
TSH (mU/L) 0.168 0.126 0.104
<5 Ref Ref Ref
≥5 −1.57 (1.14) −1.71 (1.11) −2.12 (1.29)
Gender 0.008 0.001 ¶
Female Ref Ref
Male 3.05 (1.15) 3.52 (1.08)
 Mother education level p < 0.0001 p < 0.0001 p < 0.0001
University or higher Ref Ref Ref
<University or higher 6.04 (1.28) 4.68 (1.24) 6.42 (1.43)
Child dietary supplement intake 0.003 0.006 ¶
Yes Ref Ref
No 3.53 (1.19) 3.18 (1.15)
Mother Vitality Index ¶ 0.009 ¶
Suboptimal vitality Ref
Optimal vitality −4.69 (1.77)
Maternal mental distress score p < 0.0001 ¶ ¶
Low (<4) Ref
Elevated (>4) 6.54 (1.28)
Smoking during lifetime ¶ ¶ 0.031
No Ref
Yes 2.89 (1.33)
Neonatal hospital attendance 0.023 ¶ 0.093
Yes Ref Ref
No −4.79 (2.09) −3.83 (2.27)
Child negative life events 0.008 ¶ ¶
<2 Ref
≥2 3.22 (1.20)      
PsychoTSH study (N = 310), Belgium, 2008–2014.
A higher CBCL score is related to higher developmental problems.
¶Variables not kept in the models after stepwise backward selection procedure: school attendance, child bilingualism, household incomes, rural/urban habitat, mother’s mental 
health score, iodine salt consumption, urinary iodine concentration, pregnancy duration, weight at birth, weight gain during pregnancy, mother’s age, season of birth, alcohol during 
pregnancy, previous miscarriage, breastfeeding, type of delivery, parity.
N, number of subject; Ref, referent.
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